Pharming Group to attend the following Investor Conferences in June
LEIDEN,
- Jefferies Healthcare Conference,
New York ,U.S. , June 7 - 9
Pharming's CEO, Sijmen de Vries, will present on Thursday, June 8 at 10:30 EST / 16:30 CEST. A live webcast and replay of the presentation will be available in the "Upcoming Events" and "News" sections of Pharming's website. - Stifel European Healthcare Summit,
Bordeaux, France , June 28 - 30 - IEX Beleggers dag (IEX Shareholder's day), Bussum,
the Netherlands , June 30
Pharming's CEO, Sijmen de Vries, will present on Friday, June 30 at 11:30 CEST / 05:30 EST
Pharming's management will be available for one-to-one investor meetings during the Jefferies and Stifel conferences.
For more information about these conferences, or to schedule a one-to-one with Pharming's management team, please contact your Jefferies or Stifel representative, or send an email to Pharming's Investor Relations team to investor@pharming.com.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden,
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming Group, Leiden,
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
Heather Robertson, Investor Relations & Corporate Communications Manager
E: investor@pharming.com
FTI Consulting,
Victoria Foster Mitchell/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication,
Leon Melens T: +31 6 53 81 64 27 E: pharming@lifespring.nl
View original content to download multimedia:https://www.prnewswire.com/news-releases/pharming-group-to-attend-the-following-investor-conferences-in-june-301833984.html
SOURCE Pharming Group N.V.